NewLimit
NewLimit is a biotechnology company focusing on developing epigenetic reprogramming therapies that aid with illnesses that are normally associated with aging.
B2X
CEO
Crunchbase URL
Founded Date
2021
0
Founder
Latest Funding Round Date
May 6, 2025
Latest Funding Round Amount (USD)
130,000,000
Latest Funding Type
LinkedIn URL
Location
Motto/Tagline
Extending human healthspan
0
Number of Employees (Ranges)
11 – 50
0
Phone Number
+14156039539
Pitchbook URL
Total Funding Amount (USD)
170,000,000
Twitter URL
Official Website
YouTube Channel
Find more companies like NewLimit
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
